tirzepatide and sleep apnea for the treatment of obstructive obesity Apnea: An Evolving Therapeutic Landscape with an Emerging Role Incretin-Based Therapies Tirzepatide for Sleep Apnea |

Jill 24:54 Gosh, thanks for explaining that

Regulatory Context and Industry Response This announcement marks one of the first major drug safety signals emerging from clinical use rather than trial data

Standard GLP-1 eligibility thresholds - based on the FDA-approved drug labeling for Wegovy and Zepbound, which guides how clinicians think about the category - generally include a BMI of 30 or higher (obese), or a BMI of 27 or higher with at least one weight-related comorbidity such as high blood pressure, high cholesterol, or type 2 diabetes

Its absorbed in the small intestine and quickly excreted, so it doesnt spike your blood sugar, making it an attractive alternative for people with diabetes

The challenge isn't knowing you should drink more water

"When it comes to balancing our body, healing the gut, reversing autoimmunity, and achieving optimal healthwe are a lot like a car that wont run right